Pfizer Gets $1.95 Billion to Produce Coronavirus Vaccine by Year's End

Written by <a href="index.php?option=com_comprofiler&task=userProfile&user=55193"><span class="small">Noah Weiland, The New York Times</span></a>

Wednesday, 22 July 2020 08:24

Excerpt: "The Trump administration on Wednesday announced a nearly $2 billion contract with the pharmaceutical giant Pfizer and a smaller German biotechnology company for up to 600 million doses of a coronavirus vaccine."

The first patient enrolled in Pfizer's Covid-19 vaccine trial receiving an injection at the University of Maryland School of Medicine in Baltimore in May. (photo: University of Maryland School of Medicine/AP)

ALSO SEE: 5 Key Takeaways From Tuesday's Big Coronavirus Vaccine Hearing

Pfizer Gets $1.95 Billion to Produce Coronavirus Vaccine by Year's End

By Noah Weiland, The New York Times

22 July 20

Two pharmaceutical companies announced a nearly $2 billion contract for 600 million doses of a vaccine, with the first 100 million promised before the end of the year.

he Trump administration on Wednesday announced a nearly $2 billion contract with the pharmaceutical giant Pfizer and a smaller German biotechnology company for up to 600 million doses of a coronavirus vaccine.�

If the vaccine proves to be safe and effective in clinical trials, the companies say they could manufacture the first 100 million doses by December.

Under the arrangement, the federal government would obtain the first 100 million doses for $1.95 billion, with the rights to acquire up to 500 million more. Americans would receive the vaccine for free. Before it could be distributed, it would first need at least emergency approval by the Food and Drug Administration.

JComments